Short-term group schema therapy for XXXX : a pilot study.

@entity1 @entity308 @entity148 @entity17649 @entity1314
Schema Therapy has shown promising results for @entity1314 but there is a limited evidence base for group schema therapy ( @entity17649 ) with @entity1314 . The aim of this study was to explore the feasibility, acceptability, and preliminary effectiveness of @entity17649 in a sample of eight @entity1 with @entity1314 (with a predominant diagnosis of @entity1314 ) and high levels of comorbidity. Treatment was comprised of 20 sessions which included cognitive, behavioral, and experiential techniques. Specific schema-based strategies were chosen for a diagnostically mixed group of @entity1314 clients. Six @entity1 attended until end of treatment and two dropped-out before mid-treatment. All outcome measures showed changes with large effect sizes in @entity1314 symptom severity, @entity308 and @entity148 levels between pre-therapy and follow-up. Four @entity1 achieved a loss of @entity1314 diagnosis at the end of therapy. By follow-up, five @entity1 had achieved a loss of diagnosis, suggesting that @entity1 derived ongoing benefits from the group even after treatment ended. Six @entity1 no longer met criteria for @entity308 at the end of treatment and this was maintained for all @entity1 at 6-month follow-up. At follow-up, the majority of @entity1 showed clinically significant change on the Global Symptom Index (GSI). For the Schema Mode Inventory (SMI) maladaptive modes, the majority of @entity1 showed improvement at follow-up. At follow-up, 40% of @entity1 showed clinically significant change on the SMI adaptive modes. Qualitative feedback indicates that the group helps to normalize @entity1 ' psychological experiences and difficulties and promotes self-expression and self-disclosure, while reducing inhibition. Preliminary results suggest that short-term @entity17649 may benefit those with @entity1314 , but generalizability is limited by the small sample size and lack of control group.
